BiondVax Pharmaceuticals Overview
- Founded
-
2003

- Status
-
Private
- Employees
-
26

- Latest Deal Type
-
PIPE
- Latest Deal Amount
-
$16.7M
- Investors
-
2
BiondVax Pharmaceuticals General Information
Description
BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic.
Contact Information
Website
www.biondvax.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Angel backed
Primary Industry
Pharmaceuticals
Other Industries
Other Healthcare Services
Primary Office
- Jerusalem BioPark Building, 2nd Floor
- Hadassah Ein Kerem Campus
- Jerusalem 7403618
- Israel
+972 00-000-0000
BiondVax Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. PIPE | 17-Jul-2019 | $16.7M | 0000 | Completed | Generating Revenue | |
7. 2PO | 15-Sep-2017 | 000 | 000.00 | 000.00 | Completed | Generating Revenue |
6. PIPE | 02-Jan-2017 | 00.000 | 000.00 | Completed | Generating Revenue | |
5. 2PO | 13-May-2015 | 00.00 | 000.00 | 000.00 | Completed | Generating Revenue |
4. PIPE | 01-Nov-2010 | 00.000 | 00.000 | Completed | Generating Revenue | |
3. IPO | 18-Jun-2007 | 00000 | 00000 | Completed | Generating Revenue | |
2. Grant | 23-Dec-2005 | $1.1M | Completed | Generating Revenue | ||
1. Angel (individual) | Completed | Generating Revenue |
BiondVax Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufac
Pharmaceuticals
Jerusalem, Israel
26
As of 2022
0000
000000000
0000
BiondVax Pharmaceuticals Competitors (3)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Sinovac | Corporation | Beijing, China | 0000 | 00000 | 000000 - 000 | 00000 |
000 00000000(00000 | Corporation | Cambridge, MA | 000 | 000.00 | 00000000 | 000.00 |
00000000 000 | Formerly VC-backed | Somerville, MA | 000 | 00000 | 000000000 | 00000 |
BiondVax Pharmaceuticals Patents
BiondVax Pharmaceuticals Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2015242154-A1 | Compositions of multimeric-multiepitope influenza polypeptides and their production | Granted | 03-Apr-2014 | 000000000 | |
AU-2015242154-B2 | Compositions of multimeric-multiepitope influenza polypeptides and their production | Active | 03-Apr-2014 | 000000000 | 0 |
EP-3125931-A4 | Compositions of multimeric-multiepitope influenza polypeptides and their production | Pending | 03-Apr-2014 | 000000000 | |
JP-2017509657-A | Compositions of multimeric multiepitope influenza polypeptides and their production | Granted | 03-Apr-2014 | 000000000 | 0 |
JP-6550072-B2 | Compositions of multimeric multi-epitope influenza polypeptides and their production | Active | 03-Apr-2014 | A61K39/12 |
BiondVax Pharmaceuticals Executive Team (8)
BiondVax Pharmaceuticals Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
Amir Reichman | BiondVax Pharmaceuticals | Chief Executive Officer & Board Member | 000 0000 |
Avner Rotman Ph.D | BiondVax Pharmaceuticals | Board Member | 000 0000 |
Mark Germain | Self | Chairman & Board Member | 000 0000 |
Morris Laster MD | Self | Board Member | 000 0000 |
Samuel Moed | BiondVax Pharmaceuticals | Board Member | 000 0000 |
BiondVax Pharmaceuticals Signals
BiondVax Pharmaceuticals Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Angels High Tech Investments | Corporation | Minority | 000 0000 | 000000 0 | |
Yorkville Advisors | PE/Buyout | Minority | 000 0000 | 000000 0 |